Furthermore, 72% of adolescents with MDS and monosomy 7 had an underlying GATA2 mutation (Wlodarski et al., 2016; Fisher et al., 2017; Yoshida et al., 2020). This evidence concerns the gene GATA2 and myelodysplastic syndrome.